Leadiant Biosciences, Inc. – Trademark Portfolio
Entity Type: 03
Leadiant Biosciences, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include CYSTARAN. The owner is based in Gaithersburg, MD.
9841 Washington Boulevard, Suite 500
Gaithersburg, MD 20878
Showing of trademarks Trademarks
Trademark Classifications
Leadiant Biosciences, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Leadiant Biosciences, Inc. have?
Leadiant Biosciences, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending, 1 abandoned.
What trademark classes does Leadiant Biosciences, Inc. file in?
Leadiant Biosciences, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Leadiant Biosciences, Inc.'s most well-known trademarks?
Leadiant Biosciences, Inc.'s registered trademark portfolio includes well-known marks such as CYSTARAN. These are among 1 currently registered trademark in the portfolio.
What is Leadiant Biosciences, Inc.'s trademark registration success rate?
Leadiant Biosciences, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 3 applications are pending review.